The smart algorithm successfully targeted pulmonary capillary wedge pressure (PCWP) 8-12 mmHg during rest/exercise and PCWP ...

Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

PHILADELPHIA (WPVI) -- Ten years is a significant milestone in any relationship. But it is especially monumental for one man and the medical device that helps keep him alive. Vince McCormack is one of ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...

Outcomes and expenses were similar with transplant and elective LVAD, but urgent LVAD after ECMO fared much worse.

Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...

'Destination therapy' is a term that refers to the implantation of a left ventricular assist device (LVAD) with the aim of providing permanent circulatory support to people with advanced heart failure ...

Two years ago, on a family skiing trip to Colorado, Toby Wise was struggling to keep up. Wise, 45, had always been in good health, played football in high school and played in a softball league and a ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

Current evidence on the efficacy and safety of the implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation is adequate to support the ...